(Q44230756)

1 December 2017

title

The ceruloplasmin and hydrogen peroxide system induces alpha-synuclein aggregation in vitro (English)

1 reference

1 December 2017

1 reference

Kyung Sik Kim

1

1 reference

1 December 2017

Soo Young Choi

2

1 reference

1 December 2017

Hyeok Yil Kwon

3

1 reference

1 December 2017

Moo Ho Won

4

1 reference

1 December 2017

Tae-Cheon Kang

5

1 reference

1 December 2017

Jung Hoon Kang

6

1 reference

1 December 2017

publication date

1 July 2002

1 reference

1 December 2017

1 reference

1 December 2017

volume

84

1 reference

1 December 2017

issue

7

1 reference

1 December 2017

page(s)

625-631

1 reference

Alpha-synuclein in Lewy bodies

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Filamentous nerve cell inclusions in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Oxygen toxicity, oxygen radicals, transition metals and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Role of Oxidized LDL and Antioxidants in Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Single-chain structure of human ceruloplasmin: the complete amino acid sequence of the whole molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Normal physiology of copper metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

1 reference

7 January 2021

Intact human ceruloplasmin oxidatively modifies low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Identification of the prooxidant site of human ceruloplasmin: a model for oxidative damage by copper bound to protein surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Fragmentation of human ceruloplasmin induced by hydrogen peroxide

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Identification of two distinct synucleins from human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Carbonyl assays for determination of oxidatively modified proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Detection, characterisation, and quantification of carnosine and other histidyl derivatives in cardiac and skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Muscle buffering capacity and dipeptide content in the thoroughbred horse, greyhound dog and man.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Retardation of the senescence of cultured human diploid fibroblasts by carnosine

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Interactions among carnosine, anserine, ophidine and copper in biochemical adaptation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Oxidative stress and the pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Oxidative alterations in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Altered brain metabolism of iron as a cause of neurodegenerative diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Raised cerebrospinal-fluid copper concentration in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Aggregation of alpha-synuclein induced by the Cu,Zn-superoxide dismutase and hydrogen peroxide system

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Isoform-specific binding of human apolipoprotein E to the non-amyloid beta component of Alzheimer's disease amyloid.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Antioxidative properties of histidine-containing dipeptides from skeletal muscles of vertebrates

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

Carnosine, homocarnosine and anserine: could they act as antioxidants in vivo?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2802%2901435-9

7 January 2021

10.1016/S0300-9084(02)01435-9

Identifiers

DOI

1 reference

1 December 2017

1 reference